GlassScriptPhysician profile
Mohammad W Kagzi
NPI 1659347409
$11,041.69
in general payments reported to CMS, 2019-2025
37 companies · $2,123 in 2025
The $2,123 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,218 · 2020: $816 · 2021: $1,598 · 2022: $1,656 · 2023: $1,853 · 2024: $1,777 · 2025: $2,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,472 · Education: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,472.18 |
| Education | $280.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $2,210.30 | 2021-2025 | Wakix |
| Novo Nordisk INC | $1,223.09 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,072.77 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Jazz Pharmaceuticals INC. | $985.93 | 2019-2025 | |
| Lilly USA, LLC | $866.10 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $719.57 | 2019-2024 | Trelegy Ellipta, Nucala, Shingrix |
| Abbvie INC. | $693.12 | 2020-2025 | |
| Inspire Medical Systems, INC. | $624.94 | 2023-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $608.90 | 2019-2025 | Jardiance, Tradjenta, Ofev |
| Vanda Pharmaceuticals INC. | $268.37 | 2019-2022 | |
| Eisai INC. | $199.92 | 2019-2022 | |
| Axsome Therapeutics, INC. | $166.75 | 2024-2025 | Sunosi |
| Exact Sciences Corporation | $148.64 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $137.37 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $124.09 | 2021-2023 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $112.61 | 2021 | |
| Amgen INC. | $100.61 | 2019 | |
| Optinose US, INC. | $80.98 | 2019-2024 | |
| Abbott Laboratories | $68.63 | 2022-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $65.78 | 2019-2021 | |
| Stryker Corporation | $55.60 | 2022 | |
| Arbor Pharmaceuticals, INC. | $55.45 | 2019-2020 | |
| Philips North America LLC | $53.83 | 2021-2025 | Amara View |
| Azurity Pharmaceuticals, INC. | $47.15 | 2023-2024 | Horizant, Horizant |
| Ibsa Pharma INC. | $43.31 | 2020 | |
| Resmed Corp | $37.98 | 2025 | |
| Allergan, INC. | $37.71 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $37.51 | 2024-2025 | Lumryz |
| Gilead Sciences, INC. | $36.37 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.28 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $24.05 | 2025 | Quviviq |
| Novartis Pharmaceuticals Corporation | $19.91 | 2023 | |
| Esperion Therapeutics, INC. | $19.73 | 2021 | |
| Astellas Pharma US INC | $18.58 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.90 | 2019 | |
| Hologic Sales and Service, LLC | $17.15 | 2021 | |
| Phadia US INC. | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Kagzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.